SCHEMBL537722

SCHEMBL537722

COc1ccc(CN2CCc3c4c2nc(SC)nc4nn3Cc2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLPP Q16740 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KCNK3 O14649 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 2/20 0.37
SRC P12931 2/20 0.37
ABL1 P00519 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPBWR1 P48145 1/20 0.36
HRH2 P25021 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537635 0.83 SIGMAR1 (0.42) CLPPSIGMAR1ALDH1A1GAAALOX15
SCHEMBL537665 0.77 MAPT (0.41) SIGMAR1ALDH1A1GAAKDM4EMAPT
SCHEMBL537987 0.74 FYN (0.40) ALDH1A1GAATSHRKDM4EMAPT
SCHEMBL537857 0.72 GAA (0.42) CLPPSIGMAR1ALDH1A1GAAKDM4E
SCHEMBL2809958 0.72 BRS3 (0.39) ALDH1A1GAATSHRKDM4EMAPT
SCHEMBL538466 0.71 SIGMAR1 (0.41) CLPPSIGMAR1ALDH1A1KDM4EMAPT
SCHEMBL537723 0.70 SIGMAR1 (0.40) CLPPSIGMAR1ALDH1A1KDM4EMAPT
SCHEMBL2808269 0.69 CLPP (0.48) CLPPSIGMAR1ALDH1A1TSHRKDM4E
SCHEMBL537755 0.69 KDM4E (0.39) SIGMAR1ALDH1A1GAAKDM4EMAPT
SCHEMBL13131651 0.69 SMN1; SMN2 (0.41) ALDH1A1GAATSHRKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
EP-2414359-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-02-08 EP disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 CLPP 2832/4885SIGMAR1 4535/4885ALDH1A1 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.